Cargando…

Stimulation of the PD-1 Pathway Decreases Atherosclerotic Lesion Development in Ldlr Deficient Mice

Aim: Signaling through the coinhibitory programmed death (PD)-1/PD-L1 pathway regulates T cell responses and can inhibit ongoing immune responses. Inflammation is a key process in the development of atherosclerosis, the underlying cause for the majority of cardiovascular diseases. Dampening the exce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grievink, Hendrika W., Smit, Virginia, Verwilligen, Robin A. F., Bernabé Kleijn, Mireia N. A., Smeets, Diede, Binder, Christoph J., Yagita, Hideo, Moerland, Matthijs, Kuiper, Johan, Bot, Ilze, Foks, Amanda C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591266/ https://www.ncbi.nlm.nih.gov/pubmed/34790707 http://dx.doi.org/10.3389/fcvm.2021.740531

Ejemplares similares

Blockade of the BLT1-LTB(4) axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr(−/−) mice
por: Depuydt, Marie A. C., et al.
Publicado: (2022)

Agonistic Anti-TIGIT Treatment Inhibits T Cell Responses in LDLr Deficient Mice without Affecting Atherosclerotic Lesion Development
por: Foks, Amanda C., et al.
Publicado: (2013)

Single-cell profiling reveals age-associated immunity in atherosclerosis
por: Smit, Virginia, et al.
Publicado: (2023)

Cardiovascular risk factors: The effects of ageing and smoking on the immune system, an observational clinical study
por: Grievink, H. W., et al.
Publicado: (2022)

Complement factor C5a induces atherosclerotic plaque disruptions
por: Wezel, Anouk, et al.
Publicado: (2014)

The Effect of a 13-Valent Conjugate Pneumococcal Vaccine on Circulating Antibodies Against Oxidized LDL and Phosphorylcholine in Man, A Randomized Placebo-Controlled Clinical Trial
por: Grievink, Hendrika W., et al.
Publicado: (2020)

Antisense Oligonucleotide Inhibition of MicroRNA-494 Halts Atherosclerotic Plaque Progression and Promotes Plaque Stabilization
por: van Ingen, Eva, et al.
Publicado: (2019)

Stress-induced mast cell activation contributes to atherosclerotic plaque destabilization
por: Lagraauw, H. Maxime, et al.
Publicado: (2019)

Tc17 CD8(+) T cells accumulate in murine atherosclerotic lesions, but do not contribute to early atherosclerosis development
por: van Duijn, Janine, et al.
Publicado: (2020)

Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr (−/−) Mice Compared to Nondiabetic LDLr (−/−) Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2012)

Impact of oral administration of single strain Lactococcus lactis spp. cremoris on immune responses to keyhole limpet hemocyanin immunization and gut microbiota: A randomized placebo-controlled trial in healthy volunteers
por: Saghari, Mahdi, et al.
Publicado: (2022)

The Spectrum of B Cell Functions in Atherosclerotic Cardiovascular Disease
por: Smeets, Diede, et al.
Publicado: (2022)

Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?
por: in ‘t Veld, Aliede E., et al.
Publicado: (2019)

Whole blood assay as a model for in vitro evaluation of inflammasome activation and subsequent caspase-mediated interleukin-1 beta release
por: Tran, Thi Anh Thu, et al.
Publicado: (2019)

Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll‐Like Receptor Ligands in Human Peripheral Blood Mononuclear Cells
por: Grievink, Hendrika W., et al.
Publicado: (2020)

Uptake of (68)gallium in atherosclerotic plaques in LDLR(-/-)ApoB(100/100 )mice
por: Silvola, Johanna MU, et al.
Publicado: (2011)

Deficiency of CCAAT/Enhancer Binding Protein-Epsilon Reduces Atherosclerotic Lesions in LDLR−/− Mice
por: Okamoto, Ryoko, et al.
Publicado: (2014)

Cardiotonic Pills Plus Recombinant Human Prourokinase Ameliorates Atherosclerotic Lesions in LDLR(–/–) Mice
por: Deng, Jing-Na, et al.
Publicado: (2019)

Leukocyte Bim deficiency does not impact atherogenesis in ldlr(−/−) mice, despite a pronounced induction of autoimmune inflammation
por: Temmerman, Lieve, et al.
Publicado: (2017)

Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
por: Kritikou, Eva, et al.
Publicado: (2019)

Sample Aging Profoundly Reduces Monocyte Responses in Human Whole Blood Cultures
por: Grievink, H. W., et al.
Publicado: (2018)

Deficiency of Adipocyte IKKβ Affects Atherosclerotic Plaque Vulnerability in Obese LDLR Deficient Mice
por: Lu, Weiwei, et al.
Publicado: (2019)

Dietary Cholesterol Is Highly Associated with Severity of Hyperlipidemia and Atherosclerotic Lesions in Heterozygous LDLR-Deficient Hamsters
por: Wang, Jinjie, et al.
Publicado: (2019)

IFNγ-Stimulated B Cells Inhibit T Follicular Helper Cells and Protect Against Atherosclerosis
por: Douna, Hidde, et al.
Publicado: (2022)

Defective Autophagy in T Cells Impairs the Development of Diet-Induced Hepatic Steatosis and Atherosclerosis
por: Amersfoort, Jacob, et al.
Publicado: (2018)

Hyperlipidemia and Atherosclerotic Lesion Development in Ldlr-Deficient Mice on a Long-Term High-Fat Diet
por: Ma, Yanling, et al.
Publicado: (2012)

Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR(-/-) Mice on Western Type Diet
por: Kusters, Dennis H. M., et al.
Publicado: (2015)

Impact of atherosclerotic disease on cerebral microvasculature and tissue oxygenation in awake LDLR−/−hApoB+/+ transgenic mice
por: Lu, Yuankang, et al.
Publicado: (2019)

Deletion of Macrophage-Specific Glycogen Synthase Kinase (GSK)-3α Promotes Atherosclerotic Regression in Ldlr(−/−) Mice
por: Patel, Sarvatit, et al.
Publicado: (2022)

Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model
por: Schaftenaar, Frank H., et al.
Publicado: (2019)

Worsening of Oxidative Stress, DNA Damage, and Atherosclerotic Lesions in Aged LDLr(−/−) Mice after Consumption of Guarana Soft Drinks
por: Chisté, Layla Aparecida, et al.
Publicado: (2019)

Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR(−/−) mouse model of atherosclerosis
por: Thompson, Dawn, et al.
Publicado: (2017)

Prodigiosin Modulates the Immune Response and Could Promote a Stable Atherosclerotic Lession in C57bl/6 Ldlr-/- Mice
por: Cuevas, Alejandro, et al.
Publicado: (2020)

Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA
por: Bjune, Katrine, et al.
Publicado: (2018)

MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of LDLr Missense Variants
por: Larrea-Sebal, Asier, et al.
Publicado: (2021)

Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice
por: Bot, Martine, et al.
Publicado: (2013)

Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics
por: Depuydt, Marie A.C., et al.
Publicado: (2020)

Oxidative Stress and Lipid Accumulation Augments Cell Death in LDLR-Deficient RPE Cells and Ldlr (−/−) Mice
por: Sreekumar, Parameswaran Gangadharan, et al.
Publicado: (2022)

Effects of Low Carbohydrate High Protein (LCHP) diet on atherosclerotic plaque phenotype in ApoE/LDLR(−/−) mice: FT-IR and Raman imaging
por: Wrobel, T. P., et al.
Publicado: (2015)

In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR(–/–)ApoB(100/100) mice
por: Blanco, Fabiana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e54lfmn1tuis62ftfji1h02fp0